Algo version: 0.98b
AVIR is listed at the NASDAQ Exchange
AVIR [AVIR]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is AVIR stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Atea Pharmaceuticals, 10 years ago, but if you had invested on Friday 30th of October 2020 when the price was $30.34, you would have made a loss of $-26.58 per share or -87.61%

No, the average daily trading liquidity for Atea Pharmaceuticals, is $841 032 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Atea Pharmaceuticals, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Atea Pharmaceuticals, to be medium [0.6 out of 1]